Imatinib Mesylate recalls
Imatinib Mesylate products have been recalled 2 times, most recently on 16 Dec 2020. The recalling company is usually Shilpa Medicare. The most common reason is manufacturing (cgmp) deviations.
Total recalls2since 2020
Last 12 months0reported
Class I00% of total
Ongoing0latest 16 Dec 2020
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 2 100%Class III 0 0%
Why imatinib mesylate is recalled
Companies
Product types
By year
All imatinib mesylate recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Imatinib Mesylate Tablets 100 mg recalled by Shilpa MedicareImatinib Mesylate | Shilpa Medicare | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS II | Imatinib Mesylate Tablets 400 mg recalled by Shilpa MedicareImatinib Mesylate | Shilpa Medicare | Manufacturing (CGMP) Deviations | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.